Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Inari Medical, Inc.
  6. News
  7. Summary
    NARI   US45332Y1091

INARI MEDICAL, INC.

(NARI)
  Report
Delayed Nasdaq  -  05/27 04:00:00 pm EDT
67.51 USD   +5.34%
05/27INARI MEDICAL, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/18INSIDER SELL : Inari Medical
MT
05/13Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Inari Medical Expects Double-Digit Growth in Q4, 2021 Revenue; Shares Soar After-Hours

01/10/2022 | 04:17pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
All news about INARI MEDICAL, INC.
05/27INARI MEDICAL, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
05/18INSIDER SELL : Inari Medical
MT
05/13Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
AQ
05/12TRANSCRIPT : Inari Medical, Inc. Presents at Bank of America 2022 Healthcare Conference, M..
CI
05/04INARI MEDICAL, INC. Management's Discussion and Analysis of Financial Condition and Re..
AQ
05/04TRANSCRIPT : Inari Medical, Inc., Q1 2022 Earnings Call, May 04, 2022
CI
05/04Earnings Flash (NARI) INARI MEDICAL Posts Q1 Revenue $86.8M, vs. Street Est of $83.6M
MT
05/04Inari Medical Reports First Quarter 2022 Financial Results
AQ
05/04Inari Medical, Inc. Revises Revenue Guidance for the Full Year 2022
CI
05/04Inari Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
More news
Analyst Recommendations on INARI MEDICAL, INC.
More recommendations
Financials (USD)
Sales 2022 365 M - -
Net income 2022 -39,1 M - -
Net cash 2022 316 M - -
P/E ratio 2022 -88,8x
Yield 2022 -
Capitalization 3 586 M 3 586 M -
EV / Sales 2022 8,95x
EV / Sales 2023 7,48x
Nbr of Employees 800
Free-Float 85,0%
Chart INARI MEDICAL, INC.
Duration : Period :
Inari Medical, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INARI MEDICAL, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 67,51 $
Average target price 111,67 $
Spread / Average Target 65,4%
EPS Revisions
Managers and Directors
William H. Hoffman President, Chief Executive Officer & Director
Mitchell C. Hill Chief Financial Officer
Don B. Milder Chairman
Thomas Tu Chief Medical Officer
Tara Dunn VP-Clinical Affairs & Market Development
Sector and Competitors
1st jan.Capi. (M$)
INARI MEDICAL, INC.-26.03%3 586
NOVOCURE LIMITED11.85%8 783
MASIMO CORPORATION-50.99%7 965
GETINGE AB-29.13%7 752
SHOCKWAVE MEDICAL, INC.-2.24%6 240
PENUMBRA, INC.-48.01%5 628